Trial Summary
What is the purpose of this trial?
This trial aims to improve sentence production and comprehension in people with aphasia using a technique that subtly influences the brain to enhance language skills without the person being fully aware of it. The goal is to create lasting improvements in language abilities by frequently exposing the brain to certain language patterns.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Sentence Production Training, Sentence Production Training, Implicit Structural Priming Therapy for aphasia?
Is Sentence Training for Aphasia safe for humans?
How is Sentence Production Training different from other treatments for aphasia?
Sentence Production Training is unique because it uses structural priming, a technique that helps people with aphasia improve their ability to form sentences by repeatedly exposing them to certain sentence structures. This method focuses on implicit learning, which means patients can improve their sentence production without needing to consciously think about the rules of grammar.12345
Research Team
Jiyeon Lee, PhD
Principal Investigator
Purdue University
Eligibility Criteria
This trial is for English-speaking adults who had a stroke in the left hemisphere of their brain at least 6 months ago, causing aphasia. They should have completed high school and have normal or corrected vision and hearing. Participants must struggle with forming sentences but can use some words independently. Those with uncontrolled mental health issues, substance abuse, severe speech apraxia, or other neurological conditions affecting communication cannot join.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo structural priming training sessions to improve sentence production and comprehension
Follow-up
Participants are monitored for improvements in sentence production and comprehension post-treatment
Treatment Details
Interventions
- Sentence Production Training (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Purdue University
Lead Sponsor
Mitchell E. Daniels, Jr.
Purdue University
Chief Executive Officer since 2013
BS in Chemical Engineering from Purdue University
Dr. Elizabeth Topp
Purdue University
Chief Medical Officer since 2020
MD from Harvard Medical School
Temple University
Collaborator
Dr. Kumar Budur
Temple University
Chief Medical Officer
MD, MS
Dr. Jeffrey M. Dayno
Temple University
Chief Executive Officer
MD from Temple University School of Medicine
University of California, San Diego
Collaborator
Dr. Christopher Longhurst
University of California, San Diego
Chief Medical Officer since 2021
MD and MS in Medical Informatics from UC Davis
Patty Maysent
University of California, San Diego
Chief Executive Officer since 2016
MBA from Stanford University